Patents by Inventor Aaron Janowsky

Aaron Janowsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VMAT INHIBITORY COMPOUNDS
    Publication number: 20170298042
    Abstract: Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods of treatment using said compounds and pharmaceutical compositions.
    Type: Application
    Filed: December 7, 2016
    Publication date: October 19, 2017
    Applicants: Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs, Organix Inc.
    Inventors: Aaron Janowsky, Peter Meltzer
  • VMAT inhibitory compounds
    Patent number: 9546151
    Abstract: Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods of treatment using said compounds and pharmaceutical compositions.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: January 17, 2017
    Assignees: Oregon Health & Science University, The United States of America as Represented by the Department of Veteran Affairs, Organix Inc.
    Inventors: Aaron Janowsky, Peter Meltzer
  • VMAT INHIBITORY COMPOUNDS
    Publication number: 20160031852
    Abstract: Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods of treatment using said compounds and pharmaceutical compositions.
    Type: Application
    Filed: July 31, 2015
    Publication date: February 4, 2016
    Inventors: Aaron Janowsky, Peter Meltzer
  • Radioiodinated benzamines method of their use as radioimaging agents
    Patent number: 5154913
    Abstract: Novel, substituted benzamides in radioiodinated form are useful in radiopharmaceutical compositions in nuclear medicine as imaging agents to detect, visualize, and analyze the distribution and function of the dopamine D-2 receptor in the mammalian brain. The substituted benzamides and their racemic mixtures or their optically resolved enantiomers can be made by reacting a trialyltin substituted benzamide with an acid in the presence of radioactive iodine, generated by in situ oxidation of an appropriate iodide nuclide salt.
    Type: Grant
    Filed: May 28, 1991
    Date of Patent: October 13, 1992
    Assignee: Vanderbilt University
    Inventors: Tomas de Paulis, Robert M. Kessler, Howard E. Smith, Aaron Janowsky, Jeffrey A. Clanton